Calcipotriol Monohydrate – Active Ingredient for Psoriasis Treatment and Dermatology Formulations

1. General introduction to calcipotriol monohydrate

Calcipotriol Monohydrateis a synthetic vitamin D3 analog widely recognized as a first-line topical treatment for psoriasis. This active pharmaceutical ingredient (API) plays a crucial role in regulating keratinocyte proliferation and differentiation, helping to control the excessive skin cell growth that characterizes psoriatic lesions.

In modern dermatological formulations, Calcipotriol Monohydrate is commonly developed as topical creams, ointments, and scalp solutions. Thanks to its selective mechanism of action, it delivers high therapeutic efficacy while minimizing systemic adverse effects when used according to medical guidelines.

2. Key advantages of calcipotriol monohydrate

Calcipotriol Monohydrate is highly valued in dermatology due to its clinically established benefits:

• Clinically proven efficacy, particularly in conditions associated with abnormal keratinocyte proliferation.
• Selective action on vitamin D receptors (VDR), enabling controlled regulation of skin cell growth and differentiation.
• Low systemic absorption when applied topically, contributing to a reduced risk of systemic side effects when used as directed.
• Suitable for long-term maintenance therapyunder professional medical supervision.
• Flexible combination potential, allowing co-formulation or co-administration with other active ingredients to optimize therapeutic outcomes and enhance clinical response.

3. Applications of calcipotriol monohydrate

With its selective activity on vitamin D receptors in keratinocytes, Calcipotriol Monohydrate not only manages symptoms but also targets the underlying pathogenic mechanisms at the molecular level.

Treatment of plaque psoriasis

• Inhibits excessive keratinocyte proliferation
• Promotes normalization of epidermal differentiation
• Modulates local inflammatory responses

Management of scalp psoriasis

• Reduces thick, adherent scaling
• Relieves itching and scalp irritation
• Limits diffuse erythema
• Improves overall scalp appearance

Reduction of scaling, erythema and plaque thickness

• Slows abnormal epidermal turnover
• Minimizes hyperkeratosis and scale buildup
• Thins psoriatic plaques
• Improves redness associated with inflammation

With its well-established pharmacological foundation and broad clinical validation, Calcipotriol Monohydrate plays a central role in comprehensive management strategies for hyperproliferative skin disorders in modern dermatology.

4. Commercial products using calcipotriol monohydrate 

5. Product contact information

For more information about Calcipotriol Monohydrate supply, please contact us:

• Hotline: +84 (0) 834 560 500
• Email: director@biorichgroup.com
• Website: www.biorichgroup.com
• Sample / COA Request: Please contact us via email to receive the latest samples and Certificate of Analysis (COA).